Advertisement
Singapore markets closed
  • Straits Times Index

    3,303.19
    +10.26 (+0.31%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • Dow

    38,675.68
    +449.98 (+1.18%)
     
  • Nasdaq

    16,156.33
    +315.33 (+1.99%)
     
  • Bitcoin USD

    63,501.29
    -728.63 (-1.13%)
     
  • CMC Crypto 200

    1,372.18
    +59.56 (+4.54%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Gold

    2,332.30
    +23.70 (+1.03%)
     
  • Crude Oil

    78.57
    +0.46 (+0.59%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     
  • Hang Seng

    18,578.30
    +102.38 (+0.55%)
     
  • FTSE Bursa Malaysia

    1,597.39
    +7.80 (+0.49%)
     
  • Jakarta Composite Index

    7,135.89
    +1.17 (+0.02%)
     
  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln

April 24 (Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy.

Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements.

In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.

Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing. (Reporting by Chandni Shah in Bengaluru; Editing by Mrigank Dhaniwala)